Annual SG&A
$0.00$12.56B-100.00%
Summary
- Current Value
- As of today, NVS annual SG&A is $0.00, down -100.00% on
- Historical Performance
- NVS annual SG&A is down -100.00% over the past 3 years, down -100.00% over the past 5 years
- All-Time High Comparison
- NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on
- 3-Year Low Comparison
- NVS annual SG&A vs 3-year low value is unknown
- Sector Comparison
- NVS annual SG&A is higher than 71.81% of companies in Healthcare sector
SG&A Chart
SUGGESTED SERIES
Performance
| Metric | Date | Value | 1Y | 3Y | 5Y | 15Y |
|---|---|---|---|---|---|---|
| Annual SG&A | $0.00 | -100.0% | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $3.15B | +3.0% | +9.1% | -10.7% | -29.6% | |
| TTM SG&A | $167.01B | +1205.2% | +1226.4% | +1072.8% | +889.4% | |
| Price | $146.03 | +32.6% | +39.2% | +66.0% | +172.1% | |
| Annual Operating Expenses | $24.57B | +11.4% | +20.1% | +8.2% | -7.2% | |
| Annual Operating Profit | $16.47B | +6.8% | +58.6% | +52.2% | +77.5% | |
| Annual D&A | $5.35B | -11.8% | -20.3% | +4.7% | +116.0% | |
| Annual Revenue | $54.81B | +9.0% | +29.6% | +12.6% | +9.2% |
SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 3Y | $12.56B | -100.0% | |
| 5Y | $14.89B | -100.0% | |
| All | $17.86B | -100.0% |
SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 3Y | $0.00 | N/A | |
| 5Y | $0.00 | N/A | |
| All | $0.00 | N/A |
SG&A History
FAQ
What is the current annual SG&A of NVS?
As of today, NVS annual SG&A is $0.00
What is 1-year change in NVS annual SG&A?
NVS annual SG&A is down -100.00% year-over-year
What is 3-year change in NVS annual SG&A?
NVS annual SG&A is down -100.00% over the past 3 years
How far is NVS annual SG&A from its all-time high?
NVS annual SG&A is currently -100.00% below its historical high of $17.86B set on December 31, 2011
How does NVS annual SG&A rank versus sector peers?
NVS annual SG&A is higher than 71.81% of companies in Healthcare sector
When is NVS next annual earnings release?
As of today, the next annual earnings release for NVS has not been scheduled
Quarterly SG&A
$3.15B$287.23M-8.35%
Summary
- Current Value
- As of today, NVS quarterly SG&A is $3.15B, down -8.35% on
- Historical Performance
- NVS quarterly SG&A is up +3.01% year-over-year, up +9.05% over the past 3 years
- All-Time High Comparison
- NVS quarterly SG&A is currently -37.94% below its historical high of $5.08B set on
- 3-Year Low Comparison
- NVS quarterly SG&A is +11.00% above its 3-year low of $2.84B reached on
- Sector Comparison
- NVS quarterly SG&A is higher than 99.73% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| Quarterly SG&A | $3.15B | -8.3% | +3.0% | +9.1% | -10.7% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| TTM SG&A | $167.01B | +1155.9% | +1205.2% | +1226.4% | +1072.8% | |
| Price | $146.03 | -6.6% | +32.6% | +39.2% | +66.0% | |
| Quarterly Operating Expenses | $5.96B | -5.0% | +11.3% | +18.9% | +6.0% | |
| Quarterly Operating Profit | $3.76B | +6.7% | -18.1% | +33.5% | +36.4% | |
| Quarterly D&A | $1.23B | -20.7% | +6.8% | -34.2% | -27.4% | |
| Quarterly Revenue | $13.17B | -1.3% | -0.5% | +21.6% | +6.1% |
Quarterly SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $3.50B | -9.9% | |
| 3Y | $3.50B | -9.9% | |
| 5Y | $3.99B | -20.9% | |
| All | $5.08B | -37.9% |
Quarterly SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $3.06B | N/A | +3.0% |
| 3Y | $2.84B | +11.0% | |
| 5Y | $2.84B | +11.0% | |
| All | $0.00 | N/A |
Quarterly SG&A History
FAQ
What is the current quarterly SG&A of NVS?
As of today, NVS quarterly SG&A is $3.15B
What is NVS quarterly SG&A most recent change?
NVS quarterly SG&A was down -8.35% on March 31, 2026
What is 1-year change in NVS quarterly SG&A?
NVS quarterly SG&A is up +3.01% year-over-year
How far is NVS quarterly SG&A from its all-time high?
NVS quarterly SG&A is currently -37.94% below its historical high of $5.08B set on December 31, 2010
How does NVS quarterly SG&A rank versus sector peers?
NVS quarterly SG&A is higher than 99.73% of companies in Healthcare sector
When is NVS next earnings release?
The next earnings release for NVS is on
TTM SG&A
$167.01B$2.59B-1.53%
Summary
- Current Value
- As of today, NVS TTM SG&A is $167.01B, down -1.53% on
- Historical Performance
- NVS TTM SG&A is up +1205.18% year-over-year, up +1226.42% over the past 3 years
- All-Time High Comparison
- NVS TTM SG&A is currently -47.09% below its historical high of $315.64B set on an earlier date
- 3-Year Low Comparison
- NVS TTM SG&A is at its 3-year low
- Sector Comparison
- NVS TTM SG&A is higher than 99.21% of companies in Healthcare sector
Performance
| Metric | Date | Value | 3M | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|
| TTM SG&A | $167.01B | +1155.9% | +1205.2% | +1226.4% | +1072.8% | |
| Annual SG&A | $0.00 | – | -100.0% | -100.0% | -100.0% | |
| Quarterly SG&A | $3.15B | -8.3% | +3.0% | +9.1% | -10.7% | |
| Price | $146.03 | -6.6% | +32.6% | +39.2% | +66.0% | |
| TTM Operating Profit | $16.23B | -4.8% | -0.7% | +37.8% | +59.5% | |
| TTM D&A | $5.43B | +1.5% | -8.1% | -24.4% | +0.6% | |
| TTM Revenue | $54.66B | -0.1% | +5.9% | +22.3% | +12.0% |
TTM SG&A Highs
| Period | High | Date | Current |
|---|---|---|---|
| 1Y | $178.53B | N/A | -6.5% |
| 3Y | $249.60B | N/A | -33.1% |
| 5Y | $264.42B | N/A | -36.8% |
| All | $315.64B | N/A | -47.1% |
TTM SG&A Lows
| Period | Low | Date | Current |
|---|---|---|---|
| 1Y | $167.01B | N/A | at low |
| 3Y | $167.01B | N/A | at low |
| 5Y | $167.01B | N/A | at low |
| All | $23.86B | N/A | +600.0% |
TTM SG&A History
FAQ
What is the current TTM SG&A of NVS?
As of today, NVS TTM SG&A is $167.01B
What is NVS TTM SG&A most recent change?
NVS TTM SG&A was down -1.53% on March 31, 2026
What is 1-year change in NVS TTM SG&A?
NVS TTM SG&A is up +1205.18% year-over-year
How does NVS TTM SG&A rank versus sector peers?
NVS TTM SG&A is higher than 99.21% of companies in Healthcare sector
When is NVS next earnings release?
The next earnings release for NVS is on
Selling, General & Administrative Expenses Formula
SG&A = Operating Expenses − Cost Of Goods Sold − R&D
Data Sources & References
- NVS Official Website www.novartis.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1114448/000111444826000004/0001114448-26-000004-index.htm
- NVS Profile on Yahoo Finance finance.yahoo.com/quote/NVS
- NVS Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/nvs